BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2568884)

  • 1. Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome.
    Decker HJ; Gemmill RM; Neumann HP; Walter TA; Sandberg AA
    Cancer Genet Cytogenet; 1989 Jun; 39(2):289-93. PubMed ID: 2568884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease.
    King CR; Schimke RN; Arthur T; Davoren B; Collins D
    Cancer Genet Cytogenet; 1987 Aug; 27(2):345-8. PubMed ID: 3594418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3p involvement in a renal cell carcinoma in von Hippel-Lindau syndrome. Region of tumor breakpoint clustering on 3p?
    Decker HJ; Neumann HP; Walter TA; Sandberg AA
    Cancer Genet Cytogenet; 1988 Jul; 33(1):59-65. PubMed ID: 3164241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
    Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
    Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL).
    Decker HJ; Klauck SM; Lawrence JB; McNeil J; Smith D; Gemmill RM; Sandberg AA; Neumann HH; Simon B; Green J
    Cancer Genet Cytogenet; 1994 Oct; 77(1):1-13. PubMed ID: 7923076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of renal cell carcinoma.
    Daniel LN; Linehan WM
    Semin Urol; 1989 Nov; 7(4):258-63. PubMed ID: 2575784
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific genetic change in tumors associated with von Hippel-Lindau disease.
    Tory K; Brauch H; Linehan M; Barba D; Oldfield E; Filling-Katz M; Seizinger B; Nakamura Y; White R; Marshall FF
    J Natl Cancer Inst; 1989 Jul; 81(14):1097-101. PubMed ID: 2738940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The region of common allelic losses in sporadic renal cell carcinoma is bordered by the loci D3S2 and THRB.
    van der Hout AH; van der Vlies P; Wijmenga C; Li FP; Oosterhuis JW; Buys CH
    Genomics; 1991 Nov; 11(3):537-42. PubMed ID: 1685475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. del(3p)(p13p21) in renal cell adenoma and del(4p)(p14) in bilateral renal cell carcinoma in two unrelated patients with von Hippel-Lindau disease.
    Bergerheim US; Frisk B; Stellan B; Collins VP; Zech L
    Cancer Genet Cytogenet; 1990 Oct; 49(1):125-31. PubMed ID: 2397466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome.
    Goodman MD; Goodman BK; Lubin MB; Braunstein G; Rotter JI; Schreck RR
    Cancer; 1990 Mar; 65(5):1150-4. PubMed ID: 2302664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
    Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
    Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p.
    Brauch H; Pomer S; Hieronymus T; Schadt T; Löhrke H; Komitowski D
    World J Urol; 1994; 12(3):162-8. PubMed ID: 7951344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
    Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss analysis of tumor suppressor genes regardless of heterozygosity: von Hippel-Lindau gene loss in renal cell carcinoma.
    Mochida J; Esumi M; Kitajima A; Okada K
    J Urol; 2008 Aug; 180(2):724-8. PubMed ID: 18554638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
    Decker HJ; Neuhaus C; Jauch A; Speicher M; Ried T; Bujard M; Brauch H; Störkel S; Stöckle M; Seliger B; Huber C
    Hum Genet; 1996 Jun; 97(6):770-6. PubMed ID: 8641695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma.
    Zeiger MA; Zbar B; Keiser H; Linehan WM; Gnarra JR
    Genes Chromosomes Cancer; 1995 Jul; 13(3):151-6. PubMed ID: 7669733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial cerebellar hemangioblastoma associated with renal cell carcinoma].
    Kubo Y; Waga S; Kojima T; Itou H; Matsubara T
    Rinsho Shinkeigaku; 1987 Nov; 27(11):1388-94. PubMed ID: 3447798
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytogenetics of renal cell carcinomas associated with von Hippel-Lindau disease.
    Kovacs G; Emanuel A; Neumann HP; Kung HF
    Genes Chromosomes Cancer; 1991 Jul; 3(4):256-62. PubMed ID: 1958591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic abnormalities associated with renal cell carcinoma.
    Maloney KE; Norman RW; Lee CL; Millard OH; Welch JP
    J Urol; 1991 Sep; 146(3):692-6. PubMed ID: 1875474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.